Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-24 @ 9:44 PM
NCT ID:
NCT01881932
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven stage I-III carcinoma of the breast OR histologically proven stage I-III colorectal carcinoma.
* Receiving adjuvant or neoadjuvant chemotherapy that includes a taxane or oxaliplatin.
* While on chemotherapy, develop greater than or equal to NCI-CTC grade 2 CIPN.
* Eastern Cooperative Oncology Group performance status 0-2.
* The patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
Exclusion Criteria:
* Prior acupuncture within one year of enrollment.
* Known metastatic (stage IV) breast or colorectal cancer involvement.
* Pre-existing peripheral neuropathy before chemotherapy is initiated
* Currently taking anti-neuropathy medication such as gabapentin, or pregabalin.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01881932
Study Brief:
Protocol Section:
NCT01881932